What is the clinical significance of the PaO₂/FiO₂ (PF) ratio and creatine kinase (CK) levels?

Clinical Significance of PaO₂/FiO₂ (PF) Ratio and Creatine Kinase (CK)

The PF ratio is a critical marker for assessing respiratory failure severity and guiding intensive care decisions, while CK levels serve as a diagnostic tool for neuromuscular disorders and tissue injury—these are fundamentally different biomarkers with distinct clinical applications.

PaO₂/FiO₂ (PF) Ratio

Definition and Classification

The PF ratio measures the ratio of arterial oxygen pressure to the fraction of inspired oxygen, serving as the cornerstone for defining and stratifying acute respiratory distress syndrome (ARDS) 1, 2:

• Mild ARDS: PF ratio 201-300 mmHg
• Moderate ARDS: PF ratio 101-200 mmHg
• Severe ARDS: PF ratio ≤100 mmHg

Clinical Significance for Mortality and Management

The PF ratio directly determines ventilator management strategies and predicts mortality risk. According to the 2017 ATS/ESICM/SCCM guidelines, patients with severe ARDS (PF ratio ≤100 mmHg) require prone positioning for >12 hours daily—a strong recommendation based on moderate-quality evidence 2. The 2024 update reinforces that higher PEEP strategies should be used in moderate to severe ARDS 3.

For ICU admission decisions, a PF ratio ≤250 mmHg is a minor criterion for severe community-acquired pneumonia, and when combined with at least 2 other minor criteria, mandates ICU-level care 4. In pediatric populations, children requiring FiO₂ ≥0.50 to maintain oxygen saturation >92% need continuous cardiorespiratory monitoring 5.

Prognostic Value Beyond ARDS

The PF ratio predicts outcomes across multiple critical conditions:

• Liver transplant candidacy: PF ratio <150 mmHg with severe ARDS is a contraindication to transplant, while moderate hypoxemia (PF ≥150) may be acceptable 6
• Thrombotic risk: PF ratio <200 independently predicts arterial/venous thrombotic events (OR 1.718,95% CI 1.085-2.718) 7
• Pulmonary embolism mortality: The optimal cutoff of PF <265 predicts in-hospital mortality (AUC 0.765) 8

Ventilator Management Algorithm Based on PF Ratio

1. PF ratio >300: Consider noninvasive ventilation with close monitoring 1
2. PF ratio 200-300 (mild ARDS): Low tidal volume ventilation (4-8 mL/kg predicted body weight), plateau pressure ≤30 cm H₂O 2
3. PF ratio 100-200 (moderate ARDS): Add higher PEEP strategy without prolonged recruitment maneuvers 3
4. PF ratio ≤100 (severe ARDS): Implement prone positioning >12 hours/day, consider neuromuscular blockade early in course 9, 2

Critical pitfall: Do not use prolonged recruitment maneuvers (PEEP >35 cm H₂O for >60 seconds) in moderate to severe ARDS—this is a strong recommendation against based on increased mortality risk 3.

Creatine Kinase (CK) Levels

Clinical Significance for Diagnosis

CK serves primarily as a diagnostic marker for neuromuscular disorders, myocardial injury, and tissue damage, not as a severity marker for respiratory disease. The clinical interpretation requires understanding population-specific reference ranges.

Race and Sex-Specific Reference Ranges

Standard laboratory cutoffs significantly underperform compared to population-adjusted values 10:

• White men: 97.5th percentile = 382 IU/L (95% CI 295-469)
• Black men: 97.5th percentile = 1,001 IU/L (95% CI 718-1,284)
• White women: 97.5th percentile = 295 IU/L (95% CI 216-374)
• Black women: 97.5th percentile = 487 IU/L (95% CI 310-664)

Black patients have 5-8 times higher odds of elevated CK compared to white patients, independent of body composition 10. Using standard laboratory cutoffs without considering race leads to unnecessary workups and false-positive results.

Diagnostic Thresholds for Neuromuscular Disorders

The European Federation of Neurological Societies (EFNS) defines elevated CK as 1.5 times the upper limit of normal, but this significantly reduces sensitivity 11:

• CK >1,000 IU/L: High likelihood ratio (11.04) for myopathies, essentially excludes polyneuropathy 11
• CK >1,000 IU/L: Positive predictive value of 90.3% for identifying inflammatory myopathies or neuromuscular disorders 12
• Baseline CK at laboratory cutoffs: Sensitivity 77.0%, specificity 66.7%, PPV 87.3% for neuromuscular disorders 12

Clinical Applications Beyond Neuromuscular Disease

CK elevation occurs in multiple non-cardiac, non-neuromuscular conditions:

• Organophosphorus poisoning: CK correlates strongly with Peradeniya Organophosphorus Poisoning scale (Spearman's rho=0.831); median CK in severe poisoning is 1,122 IU/L versus 240 IU/L in mild cases 13
• Malignancy screening: CK-MB/CK ratio >1.0 found in 44% of cancer patients, particularly colorectal and prostatic carcinoma with metastases 14

Practical Interpretation Algorithm

1. CK <1.5× upper limit (race/sex-adjusted): Neuromuscular disorder unlikely; consider alternative diagnoses
2. CK 1.5-10× upper limit: Pursue targeted workup based on clinical context; consider statin myopathy, inflammatory myopathy, or recent exercise
3. CK >1,000 IU/L: High probability of significant myopathy; proceed with EMG, muscle biopsy consideration, and myositis-specific antibodies 12, 11
4. CK-MB > total CK: Consider malignancy screening, particularly if no cardiac symptoms 14

Critical pitfall: Do not use standard laboratory reference ranges for CK interpretation without considering patient race and sex—this leads to over-investigation in Black patients and potential under-diagnosis in others 10.

Key Distinction

These biomarkers serve entirely different clinical purposes: PF ratio guides respiratory support intensity and predicts mortality in critically ill patients with respiratory failure, while CK identifies tissue injury patterns, particularly neuromuscular disease. They should not be conflated or used interchangeably in clinical decision-making.